Reversing primary anti-PD-1 resistance with ipilimumab and nivolumab

Project: Research project

Project Details


Co-Investigator Jeffrey A. Sosman MD is a Professor of Medicine and co-Leader of the Translational Research in Solid tumors program (TRIST) will be involved in overseeing all the accrual on the clinical trial and assuring that tissue collections will be obtained from all patients where it is feasible. We anticipate accrual of up to 5-10 patients and collection of tumor tissue x 2 on at least 5 patients. I will assist Dr Ribas in reviewing all results and help write up the presentation, publication and any reporting.
Effective start/end date5/1/174/30/20


  • University of California at Los Angeles (1559-S-VE910//20170615)
  • American Association for Cancer Research (1559-S-VE910//20170615)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.